Actatecan
- Product TA
- Antineoplastic
- Active Ingredient
- Irinotecan
- Route Of Administration
- IV
- Product type
- Specialty
Product Details
- Specialty
- Oncology
- Strength
- 40 mg
- Product Form
- Vial
Product Details
- Specialty
- Oncology
- Strength
- 100 mg
- Product Form
- Vial
- Registration Number
- DKI1429200249A1
Additional products
Plaxat
- Product TA
- Antineoplastic
- Active Ingredient
- Oxaliplatin
- Route Of Administration
- IV
- Product type
- Specialty
View Product
Lezra
- Product TA
- Antineoplastic
- Active Ingredient
- Letrozole
- Route Of Administration
- Oral
- Product type
- Specialty
View Product
Tinibat
- Product TA
- Antineoplastic
- Active Ingredient
- Imatinib
- Route Of Administration
- Oral
- Product type
- Specialty
View Product
Oncotaxel
- Product TA
- Antineoplastic
- Active Ingredient
- Docetaxel
- Route Of Administration
- IV
- Product type
- Specialty
View Product
Page Last Updated:
Copyright © 2024 PT Actavis Indonesia